US Broker Ratings

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth with a 5.24% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation in the health information services industry. With its cutting-edge platforms and technologies for analyzing biological systems, this California-based company..

Harrow, Inc. (HROW) Stock Analysis: A 103.68% Potential Upside in the Specialty Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector, has been making waves with its focus on ophthalmic pharmaceutical products. With a market cap of $1.27 billion, this..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 193% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is generating significant buzz among investors with its promising pipeline and substantial potential upside. The company, which..

Astrana Health Inc. (ASTH) Stock Analysis: 51% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) presents a compelling opportunity for investors in the healthcare sector, particularly those keen on medical care facilities. With a market capitalization of $1.32 billion, Astrana..

Progyny, Inc. (PGNY) Stock Analysis: 52.44% Potential Upside in the Fertility Benefits Space

Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefit solutions. With a market capitalization of $1.48 billion, this New..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 65.80% Potential Upside

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing case for investors seeking growth potential. With a..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Unlocking Potential with 107.87% Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, has been turning heads with its ambitious approach to drug discovery. While the current stock price sits at..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 94% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a key player in the healthcare sector, operates within the health information services industry with a unique approach that marries technology and drug development. Based in..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 61% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (SGRY), a prominent player in the healthcare sector, has caught the attention of investors with its intriguing potential upside of 61.44%, according to analyst ratings. This company,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyst Ratings Point to a Potential 223% Upside

Investors eyeing opportunities in the biotechnology sector might find Ocular Therapeutix, Inc. (NASDAQ: OCUL) an intriguing prospect, particularly given its compelling analyst ratings and potential upside. This Massachusetts-based biopharmaceutical company..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Aiming for a 58% Upside with Innovative Oncology Solutions

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in oncology, captivating investor interest with a potential upside of 58.03% based on current analyst projections. With a..

Concentra Group Holdings (CON) Stock Analysis: A 29.64% Potential Upside Beckons Healthcare Investors

As investors continue to search for compelling opportunities in the healthcare sector, Concentra Group Holdings Parent (CON) stands out with a remarkable potential upside of 29.64%, according to recent analyst..

QuidelOrtho Corporation (QDEL) Stock Analysis: Unveiling a Potential 109% Upside in the Healthcare Sector

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector, is making waves with its diagnostic testing solutions spread across its diversified business units. With a market capitalization of $1.13..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Growth with a 17.4% Revenue Surge

Guardian Pharmacy Services, Inc. (GRDN) is carving a niche in the healthcare sector with its innovative approach to serving long-term care facilities (LTCFs) in the United States. As a provider..

Establishment Labs Holdings Inc (ESTA): Growth Potential and Investor Sentiment Amidst a 49.3% Upside

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a substantial potential upside of 49.3%, according to analysts. The company, a key player in the healthcare sector, specifically..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Compelling 43.57% Upside Potential Amid Biotech Developments

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotech industry for its innovative approach to tackling intractable diseases. Headquartered in Pasadena, California, this $7.94 billion market cap company is..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Pacira BioSciences (PCRX): Exploring Growth Potential Amidst a Strong Analyst Consensus

Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling opportunity for investors seeking growth. Headquartered..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook Reveals 51% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company based in Waltham, Massachusetts, is gaining attention in the investor community due to its impressive growth potential and strategic focus on rare..

agilon health, inc. (AGL) Stock Analysis: Exploring the 114.63% Potential Upside Opportunity

For investors with an eye on the healthcare sector, agilon health, inc. (AGL) presents a unique opportunity within the Medical Care Facilities industry. As a company centered around providing healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds